Aperio Group’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$539K	Sell	7,344 -582	-7%	-$37.4K	﹤0.01%	1934
2020 Q3	$435K	Sell	7,926 -2,881	-27%	-$179K	﹤0.01%	1886
2020 Q2	$719K	Sell	10,807 -3,405	-24%	-$228K	﹤0.01%	1578
2020 Q1	$870K	Buy	14,212 +4,932	+53%	+$365K	﹤0.01%	1369
2019 Q4	$816K	Sell	9,280 -7,842	-46%	-$661K	﹤0.01%	1546
2019 Q3	$1.29M	Sell	17,122 -828	-5%	-$67.2K	0.01%	1264
2019 Q2	$1.53M	Sell	17,950 -99	-0.5%	-$9.79K	0.01%	1194
2019 Q1	$1.95M	Sell	18,049 -1,331	-7%	-$133K	0.01%	1048
2018 Q4	$1.64M	Sell	19,380 -2,517	-11%	-$243K	0.01%	1066
2018 Q3	$2.15M	Buy	21,897 +2,631	+14%	+$285K	0.01%	1030
2018 Q2	$2.23M	Sell	19,266 -6,757	-26%	-$742K	0.01%	980
2018 Q1	$2.57M	Sell	26,023 -29,243	-53%	-$2.96M	0.01%	893
2017 Q4	$5.79M	Buy	55,266 +3,300	+6%	+$363K	0.03%	586
2017 Q3	$5.86M	Buy	51,966 +1,140	+2%	+$124K	0.03%	549
2017 Q2	$5.7M	Buy	50,826 +16,233	+47%	+$1.83M	0.03%	538
2017 Q1	$4.03M	Buy	34,593 +14,746	+74%	+$1.63M	0.03%	633
2016 Q4	$2.09M	Sell	19,847 -27,219	-58%	-$2.85M	0.02%	806
2016 Q3	$5.2M	Sell	47,066 -3,954	-8%	-$524K	0.04%	521
2016 Q2	$7.43M	Buy	51,020 +42,632	+508%	+$6.05M	0.06%	373
2016 Q1	$1.2M	Buy	8,388 +6,421	+326%	+$912K	0.01%	963
2015 Q4	$304K	Buy	+1,967	New	+$287K	﹤0.01%	1615